Cardiogen

ExperimentalShort Peptide Bioregulator (Research)Experimental

Cardiogen is a short peptide bioregulator complex studied in cardiac tissue research for potential gene expression modulation and myocardial cellular support.

Calculate Dose

For research use only.

Key Facts

CAS: —
Molecular Weight (MW): Low molecular weight peptide fraction
Half-life: Not established (limited PK data; primarily research context)
Unit: mg
Administration Route: Oral (capsule) or Subcutaneous in research contexts
Frequency: Once daily (typical research pattern)
Last updated: 2/23/2026
Targets: Cardiomyocyte gene expression pathways

Overview

Cardiogen is a short peptide bioregulator complex studied in cardiac tissue research for potential gene expression modulation and myocardial cellular support.

Protocol

Dosage Range: 5-20 mg daily (research context; not clinically established)
Frequency: Once daily (typical research pattern)
Cycle: Common research cycles 10-30 days; varies by protocol
Administration Route: Oral (capsule) or Subcutaneous in research contexts
Reconstitution Guide: Reconstitute with bacteriostatic water if lyophilized (research only)

May vary by vendor concentration and protocol.

Science

Mechanism of Action

Proposed to modulate gene expression in cardiac tissue cells, supporting protein synthesis and cellular repair pathways in preclinical models.

Targets

Cardiomyocyte gene expression pathways

Studies

— Journal/year not available
— Journal/year not available

Benefits

Studied for cardiac tissue supportProposed support for myocardial cellular regeneration (research context)May influence vascular elasticity markers in experimental modelsCellular stress resilience research